National Health Investors (NYSE:NHI) Issues FY 2025 Earnings Guidance

Key Points

• National Health Investors (NHI) issued FY 2025 earnings guidance of $4.460-$4.500 per share, below the consensus estimate of $4.716.
• Analysts have upgraded NHI's stock to "strong-buy" and "buy" ratings, with a consensus rating of "Moderate Buy" and an average price target of $84.60.
• NHI's stock recently traded at $74.04, with a 52-week range between $65.13 and $86.13 and a market capitalization of $3.46 billion.

National Health Investors (NYSE:NHI - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 4.460-4.500 for the period, compared to the consensus earnings per share estimate of 4.716. The company issued revenue guidance of -.

National Health Investors Stock Performance

National Health Investors stock traded up $0.25 during midday trading on Monday, reaching $75.17. 195,943 shares of the company's stock were exchanged, compared to its average volume of 242,202. National Health Investors has a 52 week low of $65.13 and a 52 week high of $86.13. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91. The firm has a market cap of $3.57 billion, a price-to-earnings ratio of 24.02, a P/E/G ratio of 3.96 and a beta of 0.73. The stock's 50-day simple moving average is $71.30 and its 200 day simple moving average is $72.13.

National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%. The company had revenue of $70.27 million during the quarter, compared to analysts' expectations of $86.46 million. During the same quarter in the previous year, the company posted $1.18 earnings per share. The business's revenue was up 6.7% on a year-over-year basis. On average, analysts expect that National Health Investors will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a $0.92 dividend. The ex-dividend date is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.9%. National Health Investors's dividend payout ratio (DPR) is presently 115.02%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Wedbush upgraded shares of National Health Investors to a "strong-buy" rating in a research report on Wednesday, July 2nd. Truist Financial upgraded shares of National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 price target for the company in a report on Wednesday, July 2nd. Finally, KeyCorp upgraded shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target for the company in a report on Thursday, July 10th. Two investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, National Health Investors presently has an average rating of "Moderate Buy" and an average target price of $84.60.

Institutional Trading of National Health Investors

Several institutional investors have recently modified their holdings of NHI. Jane Street Group LLC grew its stake in shares of National Health Investors by 1,728.4% in the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust's stock worth $5,148,000 after purchasing an additional 65,885 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust's stock worth $18,460,000 after purchasing an additional 21,851 shares during the last quarter. NewEdge Advisors LLC grew its stake in shares of National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock worth $114,000 after purchasing an additional 345 shares during the last quarter. Finally, Cetera Investment Advisers grew its stake in shares of National Health Investors by 6.1% in the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust's stock worth $336,000 after purchasing an additional 275 shares during the last quarter. Institutional investors own 62.51% of the company's stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.